Prognosis
Novavax’s Covid-19 Vaccine Trials Start in India, Serum Says
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
Trials of Novavax Inc.’s Covid-19 vaccine have started in India, with the aim of launching it by September, according to Adar Poonawalla, chief executive officer at local partner Serum Institute of India Pvt.